18-20970392-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_005406.3(ROCK1):āc.2776A>Cā(p.Arg926Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000403 in 1,614,008 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0018 ( 1 hom., cov: 32)
Exomes š: 0.00026 ( 0 hom. )
Consequence
ROCK1
NM_005406.3 synonymous
NM_005406.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.87
Genes affected
ROCK1 (HGNC:10251): (Rho associated coiled-coil containing protein kinase 1) This gene encodes a protein serine/threonine kinase that is activated when bound to the GTP-bound form of Rho. The small GTPase Rho regulates formation of focal adhesions and stress fibers of fibroblasts, as well as adhesion and aggregation of platelets and lymphocytes by shuttling between the inactive GDP-bound form and the active GTP-bound form. Rho is also essential in cytokinesis and plays a role in transcriptional activation by serum response factor. This protein, a downstream effector of Rho, phosphorylates and activates LIM kinase, which in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. A pseudogene, related to this gene, is also located on chromosome 18. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 18-20970392-T-G is Benign according to our data. Variant chr18-20970392-T-G is described in ClinVar as [Benign]. Clinvar id is 769935.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.87 with no splicing effect.
BS2
High AC in GnomAd4 at 275 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ROCK1 | NM_005406.3 | c.2776A>C | p.Arg926Arg | synonymous_variant | 23/33 | ENST00000399799.3 | NP_005397.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ROCK1 | ENST00000399799.3 | c.2776A>C | p.Arg926Arg | synonymous_variant | 23/33 | 1 | NM_005406.3 | ENSP00000382697.1 | ||
ROCK1 | ENST00000583556.1 | n.238A>C | non_coding_transcript_exon_variant | 3/3 | 5 | |||||
ROCK1 | ENST00000635540.2 | n.2776A>C | non_coding_transcript_exon_variant | 23/34 | 5 | ENSP00000489185.1 |
Frequencies
GnomAD3 genomes AF: 0.00181 AC: 276AN: 152236Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
276
AN:
152236
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000533 AC: 134AN: 251214Hom.: 1 AF XY: 0.000346 AC XY: 47AN XY: 135760
GnomAD3 exomes
AF:
AC:
134
AN:
251214
Hom.:
AF XY:
AC XY:
47
AN XY:
135760
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000257 AC: 375AN: 1461654Hom.: 0 Cov.: 30 AF XY: 0.000219 AC XY: 159AN XY: 727128
GnomAD4 exome
AF:
AC:
375
AN:
1461654
Hom.:
Cov.:
30
AF XY:
AC XY:
159
AN XY:
727128
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00181 AC: 275AN: 152354Hom.: 1 Cov.: 32 AF XY: 0.00165 AC XY: 123AN XY: 74504
GnomAD4 genome
AF:
AC:
275
AN:
152354
Hom.:
Cov.:
32
AF XY:
AC XY:
123
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 20, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at